Skip Navigation
Skip to contents



26 results

Clinical Analysis of Malignant Pheochromocytoma

Choi SE, Kim YC, Kim TS, Noh DY, Youn YK, Choe KJ, Oh SK

  • J Korean Cancer Assoc.
  • 1999 Dec;31(6):1307-1314.
PURPOSE: There are no specific clinical and histopathologic characteristics of malignant pheochromocytoma and the optimal treatment modality has not been established yet. We analyzed the clinical and histopathologic features of...
Intracavitary 166 Holmium - chitosan Complex Therapy in Patients with Malignant Peritoneal or Pleural Effusions

Cho DY, Kim HS, Park JS, Jeong CK, Choi J, Lim HY, Park CH, Chun MS, Kim YM, Park KB, Kim HC

  • J Korean Cancer Assoc.
  • 1999 Dec;31(6):1297-1306.
PURPOSE: Most malignant peritoneal or pleural effusions caused by advanced malignancy are unresponsive to systemic chemotherapy except for chemotherapy sensitive tumors, and they are equally ineffective to regional therapy or...
Somatic Mutations of APC Presenting Polymorphisms in the Hamartomatous Polyps of the Colon

Kim JC, Roh SA, Kim HC, Yu CS, Beck NE, Bodmer WF

  • J Korean Cancer Assoc.
  • 1999 Dec;31(6):1288-1296.
No abstract available.
Role of ATF on Transcriptional Regulation of DNA Topoisomerase II a Gene in HL - 60 Arrested to G2 / M and M Phase

Lim K, Son MY, Choi BI, Yun KA, Zheng M, Kang TW, Lee YC, Park JI, Yoon WH, Hwang BD

  • J Korean Cancer Assoc.
  • 1999 Dec;31(6):1279-1287.
PURPOSE: To gain insight on transcriptional repression of Topo II a in HL-60 cells arrested to G2/M and M phase, the levels of Topo IIa mRNA and the binding activity...
Adaptive Change of AP DNA Endonuclease Against Genotoxic Agents in Normal and Transformed Cells

Lee YH, Jeong IC, Oh SH, Cho MY

  • J Korean Cancer Assoc.
  • 1999 Dec;31(6):1271-1278.
PURPOSE: AP DNA endonuclease (APE), an enzyme responsible for the repair of damaged DNAs, is essential for the maintenance of genetic information of cells. Deficiency of APE in certain hereditary...
The Clinical Values of Metaplasia, p 53, c - erbB2 and CEA Expression in Gallbladder Carcinoma

Kim SM, Kim SH, Chang JH, Lim SC, Suh CH

  • J Korean Cancer Assoc.
  • 1999 Dec;31(6):1261-1270.
PURPOSE: We evaluated the correlation between the carcinogenesis of gallbladder and the expression of lysozyme, p53, c-erbB2 and CEA in gallbladder lesions. MATERIALS AND METHODS: Thirty cases of gallbladder lesions (containing...
The Effect of Adjuvant Therapy for Curatively Resected Extrahepatic Bile Duct Cancer

Han WS, Park SJ, Kim SW, Kim KH, Ha SW, Bang YJ, Kim NK, Park YH

  • J Korean Cancer Assoc.
  • 1999 Dec;31(6):1253-1260.
PURPOSE: This study was attempted to evaluate the effect of adjuvant radiotherapy and chemotherapy after curative resection of extrahepatic bile duct cancer. MATERIALS AND METHODS: The authors performed a retrospective analysis...
Local Immunotherapy to Treat Metastatic Liver Cancer by Biodegradable Microspheres Containing Interleukin - 2

Suh KW, Hanes JS

  • J Korean Cancer Assoc.
  • 1999 Dec;31(6):1246-1252.
PURPOSE: We tried to elucidate antitumor effect of interleukin-2 containing miscrospheres (IL-2 MS) against intrahepatic challenge of parental cancer cells, which is clinically relevant tumor model. MATERIALS AND METHODS: Using a...
cDNA Cloning and Expression of Angiostatin, an Angiogenesis Inhibitor , from Human Liver Tissue mRNA

Park MJ, Hwang BG, Son YS, Yi DH, Lee SH, Hong SI

  • J Korean Cancer Assoc.
  • 1999 Dec;31(6):1236-1245.
PURPOSE: Angiostatin, a 38 kDa internal fragment of plasminogen, is a potent inhibitor of angiogenesis. It blocks neovascularization and growth of primary and metastatic tumors in mice. To produce recombinant...
The Effect of Combination Chemotherapy with Vinorelbine, Carboplatin, and Ifosfamide in Patients with Advanced Non-Small Cell Lung Cancer

Lee YW, Ryoo BY, Kim TY, Kim BS, Park YH, Hong HJ, Kwag JY, Lee SW, Kang YK

  • J Korean Cancer Assoc.
  • 1999 Dec;31(6):1227-1235.
PURPOSE: Despite recent advances in chemotherapy, the treatment outcome of advanced non-small cell lung cancer (NSCLC) remains poor and NSCLC is still the predominant source of cancer-related mortality in worldwide....
p 53 Expression in Non - Small Cell Lung Cancer: Its relationship to the clinical prognostic factor and smoking history

Kim MK, Kim HK, Kim IS, Han JH, Huh SJ, Ahn YC, Kim DY, Shim YM

  • J Korean Cancer Assoc.
  • 1999 Dec;31(6):1219-1226.
PURPOSE: p53 mutations are one of the most common genetic alterations in human lung cancer. Although the prognostic value of mutant p53 is still debated, it is widely accepted as...
The Prognostic Role of Vascular Endothelial Growth Factor (VEGF) Expression and Angiogenesis in Curatively Resected Non-Small Cell Lung Cancer

Lee SN

  • J Korean Cancer Assoc.
  • 1999 Dec;31(6):1210-1218.
PURPOSE: Angiogenesis is an essential component of tumor growth and metastasis, and vascular endothelial growth factor (VEGF) is one of the important angiogenic factor. To evaluate the prognostic roles of...
Korean Breast Cancer Data of 1997

Korean Breast Cancer Society

  • J Korean Cancer Assoc.
  • 1999 Dec;31(6):1202-1209.
PURPOSE: In Korea, breast cancer is the third most common cancer in female following uterine cervix cancer, stomach cancer, and the incidence is increasing year by year. MATERIALS AND METHODS: In...
Prognostic Significance of Occult Lymph Node Metastases in Breast Cancer

Park WC, Lee KK, Lee KM, Yun KJ

  • J Korean Cancer Assoc.
  • 1999 Dec;31(6):1195-1201.
PURPOSE: About 20% to 30% of patients with node-negative breast cancer die of systemic metastases in 10 years after surgery. This may be due to either early occult systemic spread...
The Predictors of Axillary Node Metastasis in 2 cm or Less Breast Cancer

Kang HS, Noh DY, Kwon OJ, Youn YK, Oh SK, Choe KJ

  • J Korean Cancer Assoc.
  • 1999 Dec;31(6):1188-1194.
PURPOSE: Axillary node involvement is the single most important prognostic variable in patients with breast cancer. If axillary lymph node status of breast cancer patients could be accurately predicted from...
Axillary Lymph Node Metastases in Patients with T1 Breast Carcinoma: Correlation with Histopathologic and Immunohistochemical Characteristics of the Primary Tumor

Kim HK, Chung JR, Lee CH, Park JH, Cho HR, Ko BK, Park YS, Woo YJ, Suh JH, Ahn SH, Gong GY

  • J Korean Cancer Assoc.
  • 1999 Dec;31(6):1179-1187.
PURPOSE: Axillary lymph node metastases (ALNM) are the most important prognostic indicator in breast carcinoma. Because of relatively low incidence of axillary metastasis in the patients with Tl breast carcinoma,...
VEGF Expression and MVD in Ductal Carcinoma of Breast

Jeong SJ, Park SJ, Cha SJ, Park YK, Chi KC, Lim HM, Park SI, Lee TJ, Park US

  • J Korean Cancer Assoc.
  • 1999 Dec;31(6):1168-1178.
PURPOSE: This study was aimed to determine the role of the VEGF and MVD expression in infiltrating ductal carcinoma of breast and to observe the correlation between the expression of...
Association of Tumor Angiogenesis with bcl - 2 Expression in Breast Cancer Patients

Kim DY, Lee HD, Jung WH

  • J Korean Cancer Assoc.
  • 1999 Dec;31(6):1159-1167.
PURPOSE: To evaluate the prognostic significances of angiogenesis and bc1-2, and association of each other, we investigated the correlation of microvessel count for angiogenesis and bcl-2 expression in breast cancer. MATERIALS...
Comparative Studies on the Polyarnine Involvement in MCF - 7 and MDA - MB - 231 Breast Cancer Cell Proliferation

Kim JH, Kim BG

  • J Korean Cancer Assoc.
  • 1999 Dec;31(6):1151-1158.
No abstract available.
Morphologic Changes and Ha - ras Mutation in DMBA - treated Rat Mammary Tissues

Kim YH, Cho HD, Kim KI, Lee JH, Lee HH, Kim YS, Kim HK, Kim IS

  • J Korean Cancer Assoc.
  • 1999 Dec;31(6):1140-1150.
PURPOSE: To understand the morphologic and molecular changes in carcinogen-induced breast tissues, DMBA (10-dimethy1-1,2 benzanthracene) was administrated in Sprague- Dawley female rats. MATERIALS AND METHODS: At 50 days of age, all...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: